Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1200 participants
INTERVENTIONAL
2023-10-03
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life
NCT01160367
A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment
NCT06509373
Advance Care Planning & Goals of Care Randomized Controlled Trial in Primary Care
NCT03434626
Advance Care Planning: Communicating With Outpatients for Vital Informed Decision
NCT04660422
PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.
NCT06022666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To determine the impact of facilitated Goals of Care Discussions (GOCDs) on the number of ICU, ventilator, and dialysis days during the index hospitalization (or until death) (composite).
2. To determine the impact of facilitated GOCDs on the number of ICU, ventilator, and dialysis days after the index hospitalization until 12 months post-admission from the index hospitalization (or until death) (composite).
3. To determine the impact of f-GOCDs on the final treatment preferences for life sustaining treatments (LSTs) documented in CODE STATUS.
4. To determine the impact of facilitated GOCDs on other outcomes including decisional conflict and quality of communication, patient satisfaction with the encounter, and place of death.
5. To determine the difference in direct patient hospital costs
6. To determine the barriers and facilitators to the implementation of GOCDs.
Design:
A prospective, single-centre, stratified, parallel group, allocation concealed, analyst-masked, randomized, pragmatic, mixed-method, comparative effectiveness trial in hospitalized elderly patients 80 years and older.
Participants:
This study will include all elderly patients admitted to the Royal Victoria Regional Health Centre in Barrie, Ontario, Canada, with an acute medical or surgical diagnosis who fulfill all the inclusion criteria and for whom none of the exclusion criteria exist.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GOCD Tool
Intensive care unit-facilitated goals-of-care discussion using web-based shared-decision making software tool
GOCD Tool
Web-based tool with 4 components; pre-admission health status; current illness prognosis for hospital survival; in-hospital cardiorespiratory arrest prognosis; values and goals of care
usual care
Usual discussions conducted by attending physician with patient
Usual care
Attending physicians responsible for GOCD during hospitalization using their usual approaches
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GOCD Tool
Web-based tool with 4 components; pre-admission health status; current illness prognosis for hospital survival; in-hospital cardiorespiratory arrest prognosis; values and goals of care
Usual care
Attending physicians responsible for GOCD during hospitalization using their usual approaches
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously or currently documented CODE STATUS preferences include any life sustaining therapies
* Duration of admission ≥ 24 hours
* English speaking, or translator present
* Competent patient or substitute decision maker
Exclusion Criteria
* Documented resuscitation preferences for comfort or supportive care
* New diagnosis of life-limiting illness on this hospital admission, for example, new diagnosis of metastatic cancer
* Clinically unstable, admitted to an intensive care unit, or currently receiving acute life support treatment (mechanical ventilation, acute dialysis, or inotropic/vasopressor support)
* Readmission after index hospitalization
* Pre-existing need for chronic mechanical ventilation (invasive mechanical ventilation via tracheostomy \> 90 days) or maintenance dialysis (peritoneal or hemodialysis \> 90 days)
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Victoria Regional Health Centre
UNKNOWN
Royal Victoria Hospital, Canada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giulio DiDiodato
Chief Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giulio DiDiodato, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Royal Victoria Regional Health Centre
Chris Martin, MD
Role: PRINCIPAL_INVESTIGATOR
Royal Victoria Regional Health Centre
Doug Austgarden, MD
Role: PRINCIPAL_INVESTIGATOR
Royal Victoria Regional Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R22-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.